Act Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-12-2024
- Paid Up Capital ₹ 0.10 M
as on 05-12-2024
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.30 M
as on 05-12-2024
- Revenue 10.50%
(FY 2022)
- Profit 171.23%
(FY 2022)
- Ebitda 200.96%
(FY 2022)
- Net Worth 44.26%
(FY 2022)
- Total Assets 15.21%
(FY 2022)
About Act Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.30 M.
Loonchand Jethmal and Amita Birla serve as directors at the Company.
- CIN/LLPIN
U74999MH2013PTC246975
- Company No.
246975
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 2013
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Act Lifesciences Private Limited offer?
Act Lifesciences Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Pharmaceutical Medicine, Anti Cancer Medicines, Cyramza, TB, Tumor & Cancer Drugs, Xgeva Injection, Common Disease Medicines, Injectable Products, Pharmaceutical Capsules.
Who are the key members and board of directors at Act Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amita Birla  | Director | 14-Aug-2013 | Current |
| Loonchand Jethmal | Director | 14-Aug-2013 | Current |
Financial Performance of Act Lifesciences.
Act Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 10.5% increase. The company also saw a substantial improvement in profitability, with a 171.23% increase in profit. The company's net worth Soared by an impressive increase of 44.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Act Lifesciences?
In 2019, Act Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Las Engineers And Consultants Private LimitedActive 20 years 11 monthsLoonchand Jethmal is a mutual person
- Lioness And Lions Club Of New Bombay Vashi FoundationActive 1 year 2 months
Loonchand Jethmal is a mutual person
Charges (Loans)
₹1.30 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 Apr 2023 | Others | ₹1.30 M | Open |
How Many Employees Work at Act Lifesciences?
Unlock and access historical data on people associated with Act Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Act Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Act Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.